ID Source | ID |
---|---|
PubMed CID | 13846689 |
SCHEMBL ID | 164076 |
MeSH ID | M000612169 |
Synonym |
---|
FT-0689654 , |
SCHEMBL164076 |
102036-29-3 |
protosappanin b |
protosappanin-b |
(-)-protosappanin b |
(7s,12as)-7,8-dihydro-7-(hydroxymethyl)-6h-dibenz[b,d]oxocin-3,7,10,11-tetrol |
mfcd20527297 |
6h-dibenz[b,d]oxocin-3,7,10,11-tetrol, 7,8-dihydro-7-(hydroxymethyl)-, (7s,12as)- |
(10s)-10-(hydroxymethyl)-8-oxatricyclo[10.4.0.0^{2,7]hexadeca-1(16),2(7),3,5,12,14-hexaene-5,10,14,15-tetrol |
(7s)-3,7,10,11-tetrahydroxy-7,8-dihydro-6h-dibenzo[b,d]oxocin-7-methanol |
A896916 |
10-(hydroxymethyl)-8-oxatricyclo[10.4.0.02,7]hexadeca-1(16),2(7),3,5,12,14-hexaene-5,10,14,15-tetrol |
DTXSID401317139 |
AS-79972 |
protosappaninb |
Protosappanin B (PTB) is a unique homoisoflavone compound isolated from Sappan Lignum (the heartwood of Caesalpinia sappan L) It is a bioactive dibenzoxocin derivative.
Excerpt | Reference | Relevance |
---|---|---|
"Protosappanin B (PSB) is a key active component of Lignum Sappan extract. " | ( Protosappanin B Exerts Anti-tumor Effects on Colon Cancer Cells via Inhibiting GOLPH3 Expression. Chen, ZC; Hong, ZS; Pan, JP; Qiu, CZ; Shi, ZS; Wang, CX; Zheng, XC; Zhuang, HB, ) | 3.02 |
"Protosappanin B (PTB) is a unique homoisoflavone compound isolated from Sappan Lignum (the heartwood of Caesalpinia sappan L)." | ( UPLC-ESI-Q-TOF/MS Based Metabolic Profiling of Protosappanin B in Rat Plasma, Bile, Feces, Urine and Intestinal Bacteria Samples. Chen, WY; Guo, DA; Liang, GY; Liu, B; Wu, YS; Xu, FF; Zheng, ZL, 2021) | 1.6 |
"Protosappanin B (PTB) is a bioactive dibenzoxocin derivative isolated from Caesalpinia sappan L. " | ( Protosappanin B protects PC12 cells against oxygen-glucose deprivation-induced neuronal death by maintaining mitochondrial homeostasis via induction of ubiquitin-dependent p53 protein degradation. Jiang, Y; Liao, LX; Song, FJ; Tu, PF; Yu, Q; Zeng, KW; Zhao, MB, 2015) | 3.3 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (20.22) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |